![Faraz Ali](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Faraz Ali
Directeur Général chez
TENAYA THERAPEUTICS, INC.
Fortune : 371 370 $ au 31/08/2026
Profil
Faraz Ali is President, Chief Executive Officer & Director at Tenaya Therapeutics, Inc. since 2026 and has been with the company since 2018.
Mr. Ali is also Director at Alliance for Regenerative Medicine since 2023.
Former roles include Head-U.S.
Marketing & Strategic Planning at Genzyme Corp.
from 2001 to 2010, Chief Business Officer at REGENXBIO, Inc. from 2016 to 2018, and Vice President-Global Commercial Development at Genetix Biotherapeutics, Inc. from 2011 to 2016.
Education includes undergraduate studies at Stanford University and an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/09/2026 | 539 782 ( 0,24 % ) | 371 370 $ | 31/08/2026 |
Postes actifs de Faraz Ali
| Sociétés | Poste | Début |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Directeur Général | 01/06/2018 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Faraz Ali
| Sociétés | Poste | Fin |
|---|---|---|
| REGENXBIO INC. | Corporate Officer/Principal | 05/01/2018 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2016 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/11/2010 |
Formation de Faraz Ali
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tenaya Therapeutics, Inc.
 Tenaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for heart failure | Health Technology |
